Work

Can we unlock the potential of IGF-1R inhibition in cancer therapy?

Year: 2014

Type: review

Source: Cancer Treatment Reviews

DOI: 10.1016/j.ctrv.2014.07.004

Authors: Helen King, Tamara Aleksic, Paul Haluska, Valentine M. Macaulay

Institutions: University of Oxford, John Radcliffe Hospital, MRC Weatherall Institute of Molecular Medicine, Mayo Clinic, Churchill Hospital

Language: English

Topic: Growth Hormone and Insulin-like Growth Factors

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Cancer Research UK, Breast Cancer Campaign, Prostate Cancer UK, Rosetrees Trust, NIHR Oxford Biomedical Research Centre, National Cancer Institute

Awards: G4061461591, G431899019, Mayo Clinic Ovarian Cancer SPORE, Mayo Clinic Breast Cancer SPORE

OpenAlex ID: W2061477949

FWCI: 3.598

Cites: 190

Cited by: 132

Related to: 10